Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Free Cash Flow (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Free Cash Flow for 7 consecutive years, with -$17.0 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow changed 0.21% to -$17.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$60.4 million through Dec 2025, down 2319.03% year-over-year, with the annual reading at -$60.4 million for FY2025, 2319.03% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$17.0 million at Fulcrum Therapeutics, down from -$14.3 million in the prior quarter.
  • The five-year high for Free Cash Flow was $58.9 million in Q2 2024, with the low at -$28.7 million in Q2 2022.
  • Average Free Cash Flow over 5 years is -$16.5 million, with a median of -$19.9 million recorded in 2021.
  • The sharpest move saw Free Cash Flow plummeted 331.2% in 2021, then surged 383.81% in 2024.
  • Over 5 years, Free Cash Flow stood at -$20.7 million in 2021, then increased by 13.65% to -$17.9 million in 2022, then crashed by 32.4% to -$23.7 million in 2023, then rose by 28.2% to -$17.0 million in 2024, then grew by 0.21% to -$17.0 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$17.0 million, -$14.3 million, and -$13.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.